Magnite director sells 10,363 shares at $23.76
Magnite director Robert F. Spillane exercised and sold 10,363 shares in an option-related transaction on September 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MAGNITE, INC. (MGNI) director Robert F. Spillane exercised stock options for 10,363 shares of common stock on September 14, 2026 at an exercise price of $5.17 per share, then sold 10,363 shares of common stock the same day at a weighted average price of $23.76 per share. The options were fully vested and granted as compensation, and this exercise left no shares remaining under that option award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F3, F2 | 10,363 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,363 | $5.17 | $54K |
| Sale | Common Stock F1 | 10,363 | $23.76 | $246K |
Footnotes (3)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.75 to $23.7901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F2. The stock options have fully vested and are immediately exercisable.
- F3. Granted as compensation for services.
Key Figures
Key Terms
weighted average price financial
stock options financial
immediately exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MAGNITE, INC. (MGNI) director Robert F. Spillane report on this Form 4?
What was the exercise price of the options Robert F. Spillane exercised in MGNI?
Was a Rule 10b5-1 trading plan used for Robert F. Spillane’s MGNI transactions?
Does Robert F. Spillane retain any options from this MGNI grant after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.